Repurposed Drugs in Cancer Therapy: What the Science Shows

prepared to take my nutritional supplements

Repurposed Drugs in Cancer Therapy: What the Science Shows- Many cancer patients eventually ask the same question: Are there existing non-cancer drugs that might help fight cancer?

This question has led researchers to study repurposed drugs—medications originally developed for other diseases that may also have anti-cancer effects.

Examples include medications used for parasites, diabetes, cholesterol, and infections. Because these drugs are already approved for human use, they often have well-understood safety profiles and relatively low cost.

While most repurposed drugs are not approved cancer treatments, growing research suggests some may influence cancer biology in meaningful ways.

This article reviews what research currently says about repurposed drugs in oncology.

Before I get to the topic of repurposed drugs in oncology, I would like to stress the idea of preparing for whatever cancer treatment you choose with:

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.

Good luck,

David Emerson

Repurposed drugs for cancers

What Are Repurposed Drugs?

Drug repurposing (also called drug repositioning) refers to the process of finding new therapeutic uses for existing medications.

Advantages of repurposed drugs include:

• Established safety profiles
• Known pharmacology and dosing
• Lower development costs
• Faster clinical translation compared to new drugs

Because developing a new cancer drug can take 10–15 years and billions of dollars, repurposing existing medications has become an increasingly attractive research strategy.

A major review in Nature Reviews Cancer notes that repurposed drugs may represent one of the most efficient pathways for expanding cancer therapies.

Why Repurposed Drugs May Work Against Cancer

Cancer cells rely on several biological pathways that many existing medications already influence.

These include:

• Cell metabolism
• Microtubule formation
• Autophagy
• Inflammation pathways
• Immune system signaling

Because of this, medications designed for completely different diseases may still interfere with cancer growth.

A large systematic analysis published in Nature Reviews Clinical Oncology identified hundreds of existing drugs with potential anti-cancer activity.

Repurposed Drugs Being Studied in Cancer

Below are several of the most commonly studied repurposed drugs in oncology research.

Fenbendazole

Fenbendazole is an anti-parasitic medication widely used in veterinary medicine.

Preclinical studies suggest it may:

• Disrupt microtubule formation in cancer cells
• Interfere with glucose metabolism
• Promote p53 tumor suppressor activity

Research suggests that fenbendazole may inhibit tumor growth in laboratory models.

However, human clinical trials are limited, and evidence remains preliminary.

Ivermectin

Ivermectin is an anti-parasitic drug used worldwide to treat infections such as river blindness.

Laboratory research suggests ivermectin may:

• Inhibit WNT-TCF signaling pathways
• Induce apoptosis (programmed cell death)
• Disrupt cancer cell proliferation

Several preclinical studies have demonstrated anti-tumor effects across multiple cancer types.

Clinical evidence is still emerging.

Mebendazole

Mebendazole is another anti-parasitic medication.

Studies show it may:

• Inhibit tubulin polymerization
• Block angiogenesis (tumor blood vessel formation)
• Slow tumor growth in several animal models

Some early clinical case reports have described tumor responses, particularly in brain cancers, but controlled trials are still needed.

Metformin

Metformin is one of the most widely used medications for type 2 diabetes.

It has attracted significant interest in oncology research because it affects cell metabolism and insulin signaling.

Studies suggest metformin may:

• Activate AMPK, a metabolic regulator
• Inhibit mTOR signaling
• Reduce circulating insulin levels (which may promote tumor growth)

Large epidemiological studies have observed lower cancer incidence and mortality in some diabetic patients using metformin.

Statins

Statins are cholesterol-lowering medications used by millions of people.

Research suggests statins may:

• Inhibit the mevalonate pathway
• Reduce cancer cell proliferation
• Influence tumor cell signaling

Some observational studies have found statin use associated with reduced cancer mortality in certain cancers.

However, clinical trial results remain mixed.

Evidence Strength: What We Know vs What We Don’t

While interest in repurposed drugs is growing, it is important to understand the strength of evidence varies widely.

Current evidence includes:

Preclinical studies

Laboratory and animal research demonstrating biological mechanisms.

Observational studies

Studies analyzing patient populations who happened to take these medications.

Early clinical trials

Small studies exploring safety and possible effectiveness.

However, for most repurposed drugs:

• Large randomized clinical trials are still limited
• Optimal dosing in cancer is unclear
• Drug combinations require further research

As a result, many oncologists remain cautious.

Why Repurposed Drugs Are Hard to Study

Despite promising research, repurposed drugs face a major obstacle:

There is little financial incentive to study them.

Most of these medications are generic and inexpensive, meaning pharmaceutical companies have limited incentive to fund large clinical trials.

This has led many researchers to call for government and nonprofit funding for repurposing research.

A major review in The Lancet Oncology highlighted this problem, describing repurposed drugs as “financially orphaned therapies.”

Integrative Oncology: Where Repurposed Drugs Fit

Some integrative oncology programs are beginning to study repurposed drugs as part of multi-target cancer treatment strategies.

These approaches may combine:

• Conventional oncology treatments
• Lifestyle interventions
• Nutritional therapies
• Evidence-based repurposed drugs

The goal is to target multiple cancer pathways simultaneously.

However, these strategies should always be discussed with an experienced oncology team.

Important Safety Considerations

Cancer patients should never start repurposed drugs without medical supervision.

Potential concerns include:

• Drug interactions with chemotherapy
• Incorrect dosing
• Side effects
• Lack of standardized treatment protocols

Even medications considered safe for other conditions may behave differently in cancer patients.

The Bottom Line

Research into repurposed drugs represents one of the most intriguing frontiers in cancer therapy.

Scientific evidence suggests several existing medications may influence cancer biology through mechanisms such as:

• Metabolic disruption
• Microtubule inhibition
• Immune modulation
• Anti-angiogenesis

However:

• Most evidence remains preclinical or observational
• Large randomized trials are still needed
• These therapies are not standard cancer treatments

For patients exploring integrative cancer strategies, repurposed drugs remain an area of active and evolving research.

To learn more about repurposed drugs and cancer-

Repurposed Drugs in Cancer Therapy: What the Science Shows
Repurposed Drugs in Cancer Therapy: What the Science Shows

Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!